| Patents for C07H 15 - Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals (17,975) |
|---|
| 02/28/2002 | WO2002015867A1 Use of beta-mannosylglycerate and derivatives in cosmetic and dermatological formulations |
| 02/28/2002 | WO2002015722A2 Treatment of helicobacter with isothiocyanates |
| 02/28/2002 | US20020026047 For use in Hydrogen Bonding Liquid Chromatography, environmental remediation by removal of undesired ions or neutral molecules, removal of phosphate for kidney dialysis, drug delivery, separation |
| 02/28/2002 | DE10040380A1 MRI contrast agent for visualization of plaque, lymph nodes, infarcted and necrotic tissue or both necrosis and tumors, comprising perfluoroalkylated metal complex having specific micelle forming properties |
| 02/26/2002 | US6350733 Aromatic derivatives substituted by a ribose, their method of preparation and application as medicine |
| 02/26/2002 | CA2052020C Pradimicin derivatives |
| 02/26/2002 | CA2024672C Indole, benzofuran,and benzothiophene containing lipoxygenase inhibiting compounds |
| 02/21/2002 | US20020022665 Anti-carcinogenic activity of hydroxylated chalcone compounds extracted from licorice root |
| 02/21/2002 | US20020022602 Benzylmaltotriosides as inhibitors of smooth muscle cell proliferation |
| 02/21/2002 | US20020022597 1-((3,4,5-trihydroxy-6-sulfomethyl-tetrahydropyran-2-yl)-),2 -(fatty acyl),3-(optionally fatty acyl)glycerol; DNA polymerase inhibitors; anticancer agents |
| 02/21/2002 | US20020022257 Three-dimensional structure and crystallization method of ribosome recycling factor (RRF) |
| 02/20/2002 | EP1180116A2 Fap-activated anti-tumor compounds |
| 02/20/2002 | EP1180109A1 Prodrug activation using catalytic antibodies |
| 02/20/2002 | EP0889898B1 Morpholinyl anthracycline derivatives |
| 02/20/2002 | CN1336933A Protecting groups for carbohydrate synthesis |
| 02/19/2002 | USRE37556 Superoxide radical inhibitor |
| 02/19/2002 | CA2023630C Use of toremifene and its metabolites for the reversal of multidrug resistance of cancer cells against cytotoxic drugs |
| 02/14/2002 | WO2002012258A1 New immunoeffector compounds |
| 02/14/2002 | WO2001021771A3 Compositions and methods for inhibiting g2 cell cycle arrest and sensitizing cells to dna damaging agents |
| 02/14/2002 | US20020019521 Separation of olefinic isomers |
| 02/14/2002 | US20020019368 Decyclization with an alkali metal or quaternary ammonium borohydride; antiinflammatory agents |
| 02/13/2002 | CN1335881A UME extract having medicinal effects and compositions containing the same |
| 02/12/2002 | CA2229410C Process for producing mixtures rich in 1,6-gps or 1,1-gpm |
| 02/07/2002 | WO2001056959B1 A substance for the use in a dietary supplementation or for the preparation of a medicament for the treatment of non-insulin dependent diabetes mellitus, hypertension and/or the metabolic syndrome |
| 02/07/2002 | US20020016300 Treating inflammatory disorders, cardiovascular diseases, occular diseases, autoimmune diseases, neurological disorders, and cancer. The compounds also can be used to treat hyperlipidemia and/or hypercholesterolemia. |
| 02/06/2002 | EP1177273A1 Highly concentrated free-flowing pearly lustre concentrates |
| 02/06/2002 | EP0728138B1 Anthracycline derivatives |
| 02/05/2002 | US6344591 Bipyramidal or prismatic crystal structure; crystallizing a syrup having a maltitol content of >92% and a maltotriitol content of <1% controlling the crystal structure; free-flowing; antiagglomerants; foods; artificial sweeteners |
| 01/31/2002 | WO2001060832A3 Pluraflavins and derivatives thereof, process for their preparation and use thereof |
| 01/31/2002 | US20020013253 Alkylpolyglucoside oligomer of given degree of oligomerization (DP), having alkyl radical of eight carbon atoms; with alkali metal hydroxide in cleaner concentrate |
| 01/31/2002 | US20020012992 Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor |
| 01/30/2002 | EP1176149A1 Novel gymnemic acid derivatives, process for the preparation thereof and use thereof as medicine |
| 01/30/2002 | EP1175888A2 Topical compositions comprising glycosylated hydroxystilbenes and their uses |
| 01/30/2002 | EP1175500A1 Method for the selective esterification of polyoles |
| 01/30/2002 | EP1175427A2 Linkers for synthesis of oligosaccharides on solid supports |
| 01/30/2002 | EP0689611B1 Improved enhancement of chemiluminescent assays |
| 01/30/2002 | CN1333784A Benzylmaltosides as inhibitors of smooth muscle cell proliferation |
| 01/30/2002 | CN1333781A Benzylglycosylamides as inhibitors of smooth muscle cell proliferation |
| 01/30/2002 | CN1333780A Benzylglycosylmmides as inhibitors of smooth muscle cell proliferation |
| 01/30/2002 | CN1333779A Benzyllactobionamides as inhibitors of smooth muscle cell proliferation |
| 01/30/2002 | CN1333778A Benzylmaltotriosides as inhibitors of smooth muscle cell proliferation |
| 01/29/2002 | US6342497 2″-deoxy hygromycin derivatives |
| 01/29/2002 | CA2149160C Propiophenone derivative and a process for preparing the same |
| 01/28/2002 | CA2354107A1 Topical compounds including glucosyl hydroxystilbenes and uses |
| 01/24/2002 | WO2000053614A8 Method for producing glyco-conjugates of 20(s)-camptothecin |
| 01/24/2002 | US20020010322 New aromatic derivatives substituted by a ribose, their preparation process and their use as medicaments |
| 01/24/2002 | US20020010177 For treating eosinophil-dependent inflammatory diseases, asthma |
| 01/24/2002 | US20020009464 Modified glycosides, compositions comprised thereof and methods of use thereof |
| 01/23/2002 | EP1174436A1 Saccharide-alkyleneoxy derivative and ink |
| 01/23/2002 | EP1174140A1 Skin preparations for external use |
| 01/23/2002 | EP1173454A1 Method for producing glyco-conjugates of 20(s)-camptothecin |
| 01/23/2002 | EP1173453A1 Crystallization of glucopyranosylalditols, crystalline glucopyranosylalditol product and use thereof |
| 01/23/2002 | EP1173414A1 N-protected amines and their use as prodrugs |
| 01/23/2002 | CN1332746A Novel derivatives from class of oleandomycin |
| 01/23/2002 | CN1332745A New compounds for treatment of cancer |
| 01/23/2002 | CN1332173A Prepn of theasaponine |
| 01/23/2002 | CN1332172A Acetamido lactose PEG glycoside and dimer with activity of resisting tumor metastasis |
| 01/22/2002 | US6340746 Thiolamine or selenolamine conjugate with antioxidant vitamin; nontoxic |
| 01/22/2002 | US6340670 Therapy of restenosis resulting from a vascular angioplasty procedure, vascular reconstructive surgery, or organ or tissue transplantation, for inhibiting angiogenesis in a malignant tumor, sarcoma, or neoplastic tissue in a mammal |
| 01/22/2002 | US6340665 Providing water-containing alkaline sugar surfactant selected from alkyl or alkenyl oligoglycoside, a fatty acid-n-alkyl polyhydroxyalkylamide; providing a thin-layer evaporator or dryer having rotating internals; neutralization |
| 01/17/2002 | WO2002004473A1 A method of crystallizing maltitol |
| 01/17/2002 | WO2001059067A3 A group of anti-cancer compounds with specific structure and their production method |
| 01/17/2002 | US20020007050 Process for preparing alkyl and/or alkenyl oligoglycosides |
| 01/17/2002 | US20020006900 Colon cancer KH-1 and N3 antigens |
| 01/17/2002 | US20020006884 Using ion exchange resin; crystallization |
| 01/17/2002 | DE10031955A1 Curcumin-Derivate mit gegenüber Curcumin verbesserter Wasserlöslichkeit und diese enthaltende Arzneimittel Curcumin derivatives with respect to curcumin improved water solubility and pharmaceutical compositions containing them |
| 01/16/2002 | EP1172369A1 Synthesis of 2-deoxy-2-fluoro-arabinose derivates |
| 01/16/2002 | EP1172368A1 Reduced malto-oligosaccharides |
| 01/16/2002 | EP1172108A1 Novel immunosuppressants |
| 01/16/2002 | EP1172107A1 Drugs containing sulfopyranosylacylglycerol derivatives |
| 01/16/2002 | EP1171130A1 Pharmaceutical compositions containing poly(adp-ribose) glycohydrolase inhibitors and methods of using the same |
| 01/16/2002 | CN1331601A Antiprotozoal saponins |
| 01/16/2002 | CN1331599A Compounds and their therapeutic use with diabetic complications |
| 01/15/2002 | US6339162 Process for the preparation of tetrahydropyran derivatives |
| 01/15/2002 | US6339146 Cycloalkylated beta-glucoside |
| 01/15/2002 | CA2109304C Glycosylated prodrugs, and their processes of preparation and use |
| 01/13/2002 | CA2350434A1 Reduced malto-oligosaccharides |
| 01/10/2002 | WO2002002595A1 Amphipathic linear peptides and compositions containing same |
| 01/10/2002 | WO2002002581A1 Molasses-containing maltitol crystal and process for producing the same |
| 01/10/2002 | WO2002002127A1 Extended type 1 chain glycosphingolipids as tumor-associated antigens |
| 01/10/2002 | CA2414355A1 Amphipathic linear peptides and compositions containing same |
| 01/09/2002 | EP1169327A1 L-arabino-disaccharides of anthracyclines, processes for their preparation, and pharmaceutical compositions containing them |
| 01/09/2002 | EP1169298A2 Pharmaceutical compounds |
| 01/09/2002 | EP1169294A2 Pharmaceutical compounds |
| 01/09/2002 | CN1330082A Process for extracting and separating astragalus polyase and astragalus saponin |
| 01/08/2002 | US6337390 Monosaccharide lipid linked to anomeric carbon of sialic acid or kdn |
| 01/03/2002 | WO2002000673A1 Phosphoglycan messengers and their medical uses |
| 01/03/2002 | WO2001073125A3 High throughput screening array containing porous material |
| 01/03/2002 | WO2001044247A3 Agents and methods for the treatment of proliferative diseases |
| 01/03/2002 | WO2001039726A3 Antimicrobial 2-deoxystreptamine compounds |
| 01/03/2002 | US20020002274 Process for the production of perbenzylated 1-0-glycosides |
| 01/03/2002 | DE10029709A1 Verfahren zur Herstellung von dendritischen Strukturen A process for the preparation of dendritic structures |
| 01/03/2002 | CA2427742A1 Phosphoglycan messengers and their medical uses |
| 01/02/2002 | EP1167374A1 Glycosphingolipid |
| 01/02/2002 | EP1166786A1 Medicinal compositions |
| 01/02/2002 | EP1165581A1 Method for the production of 4'-demethyl - 4'-phosphate-2",3" - bis pentafluorophenoxyacetyl - 4",6"-ethylidene - beta-d- glucoside epipodophyllotoxin and the salts thereof |
| 01/02/2002 | EP1165580A1 Catalytic method for modifying carbohydrates, alcohols, aldehydes or polyhydroxy compounds |
| 01/02/2002 | EP1165578A2 Methods and compositions for the manufacture of c-3' and c-4' anthracycline antibiotics |
| 01/02/2002 | EP1165563A1 Bicyclic heterocycles, method for producing them and their use as herbicides and pharmaceutical agents |
| 01/02/2002 | EP0817789B1 Bis-maleimido cross-linking agents |